French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

331 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-07-17

Study Completion Date

2011-11-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is conducted in Europe. The aim of this study is to extract data from the French National Registry holding information about patients having initiated growth hormone therapy with the objective to describe patients receiving growth hormone therapy, assess efficacy and safety of somatropin (Norditropin® SimpleXx®) and evaluate treatment compliance.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

French National Registry of Children Born Small for Gestational Age Treated With Somatropin

NCT01578135

Growth Disorder Small for Gestational Age

COMPLETED

Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)

NCT00597480

Small for Gestational Age

TERMINATED PHASE4

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

NCT01562834

Growth Hormone Disorder Adult Growth Hormone Deficiency

COMPLETED PHASE4

An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

NCT01009905

Growth Hormone Disorder Pituitary Dwarfism Hypopituitarism

COMPLETED

Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients

NCT00570011

Growth Hormone Deficiency

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Growth Hormone Disorder Adult Growth Hormone Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Users of somatropin

somatropin

Intervention Type DRUG

Data are extracted from the French National Registry "l'Observatoire National des Prescriptions et Consommations de Médicaments" to where physicians report data about growth hormone treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

somatropin

Data are extracted from the French National Registry "l'Observatoire National des Prescriptions et Consommations de Médicaments" to where physicians report data about growth hormone treatment

Intervention Type DRUG